Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
981
-
Total 13F shares, excl. options
-
228M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$60B
-
Value change
-
+$650M
-
Put/Call ratio
-
0.31
-
Number of buys
-
366
-
Number of sells
-
-480
-
Price
-
$262.63
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2018
1,114 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q4 2018.
Elevance Health, Inc. - Common Stock (ELV) has 981 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 228M shares
.
Largest 10 shareholders include BlackRock Inc. (23.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (19.7M shares), Vanguard Group Inc (19.1M shares), FMR LLC (11.3M shares), STATE STREET CORP (10.9M shares), WELLINGTON MANAGEMENT GROUP LLP (6.03M shares), Viking Global Investors LP (5.1M shares), BAILLIE GIFFORD & CO (4.46M shares), Invesco Ltd. (3.48M shares), and GEODE CAPITAL MANAGEMENT, LLC (3.39M shares).
This table shows the top 981 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.